Literature DB >> 15019894

Analysis of pravastatin to prevent recurrence of atrial fibrillation after electrical cardioversion.

Arnljot Tveit1, Morten Grundtvig, Torstein Gundersen, Paul Vanberg, Anne Grete Semb, Even Holt, Lars Gullestad.   

Abstract

To test the hypothesis that a statin could reduce the recurrence rate of atrial fibrillation after electrical cardioversion (EC), we performed an open, controlled multicenter study. Patients (n = 114) who had atrial fibrillation >48 hours and who were scheduled for EC were randomized to receive 40 mg of pravastatin once daily for 3 weeks before and 6 weeks after EC or no drug in addition to standard therapy. Pravastatin did not reduce the recurrence rate of atrial fibrillation after EC.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15019894     DOI: 10.1016/j.amjcard.2003.12.009

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Atrial fibrillation: basic mechanisms, remodeling and triggers.

Authors:  Akiko Shiroshita-Takeshita; Bianca J J M Brundel; Stanley Nattel
Journal:  J Interv Card Electrophysiol       Date:  2005-09       Impact factor: 1.900

2.  Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction.

Authors:  Ibrahim R Hanna; Brent Heeke; Heather Bush; Lynne Brosius; Diane King-Hageman; Samuel C Dudley; John F Beshai; Jonathan J Langberg
Journal:  Heart Rhythm       Date:  2006-05-09       Impact factor: 6.343

3.  Pravastatin treatment before coronary artery bypass grafting for reduction of postoperative atrial fibrillation.

Authors:  Kiyoshi Tamura; Hirokuni Arai; Fusahiko Ito; Takeshi Someya; Tomohiro Ushiyama; Naoto Miyagi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2010-03-11

Review 4.  The role of statin therapy in the prevention of atrial fibrillation: a meta-analysis of randomized controlled trials.

Authors:  Wen-tong Fang; Hong-Jian Li; Haibo Zhang; Su Jiang
Journal:  Br J Clin Pharmacol       Date:  2012-11       Impact factor: 4.335

5.  Predictors of incident atrial fibrillation and influence of medications: a retrospective case-control study.

Authors:  James A Hodgkinson; Clare J Taylor; F D Richard Hobbs
Journal:  Br J Gen Pract       Date:  2011-06       Impact factor: 5.386

6.  Angiotensin receptor blockers and statins could alleviate atrial fibrosis via regulating platelet-derived growth factor/Rac1/nuclear factor-kappa B Axis.

Authors:  Dongfang Yang; Jia Yuan; Gan Liu; Zhiyu Ling; Haiyan Zeng; Yunqing Chen; Yue Zhang; Qiang She; Xue Zhou
Journal:  Int J Med Sci       Date:  2013-04-26       Impact factor: 3.738

7.  Statin use is associated with lower risk of atrial fibrillation in women with coronary disease: the HERS trial.

Authors:  C N Pellegrini; E Vittinghoff; F Lin; S B Hulley; G M Marcus
Journal:  Heart       Date:  2009-01-28       Impact factor: 5.994

Review 8.  Pleiotropic effects of statins in atrial fibrillation patients: the evidence.

Authors:  Hadi Ar Hadi; Wael Al Mahmeed; Jassim Al Suwaidi; Samer Ellahham
Journal:  Vasc Health Risk Manag       Date:  2009-06-29

Review 9.  Primary and secondary prevention of atrial fibrillation with statins and polyunsaturated fatty acids: review of evidence and clinical relevance.

Authors:  Irene Savelieva; Antonios Kourliouros; John Camm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-11-25       Impact factor: 3.000

10.  The risk of atrial fibrillation in patients with rheumatoid arthritis.

Authors:  Seoyoung C Kim; Jun Liu; Daniel H Solomon
Journal:  Ann Rheum Dis       Date:  2013-04-20       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.